IF a sequential-then-concurrent pharmacological regimen of MitoQ (mitoquinone mesylate, 500 µM in drinking water, administered ad libitum) followed by bezafibrate (0.5% w/w in chow) — with MitoQ initiated two weeks prior to bezafibrate co-administration to pre-condition the mitochondrial redox environment — is administered to aged C57BL/6J male mice (22–24 months), compared to vehicle control, MitoQ monotherapy, and bezafibrate monotherapy arms,

THEN a measurable reduction in hippocampal mutant mtDNA heteroplasmy fraction (≥20% reduction in the ratio of deletion-bearing to wild-type mtDNA copies, quantified by long-range PCR and droplet digital PCR), combined with a ≥30% increase in hippocampal mtDNA copy number, ≥25% reduction in 4-hydroxynonenal (4-HNE) adducts, and statistically significant improvement in Morris Water Maze escape latency and probe trial performance relative to vehicle-treated aged controls, will be observed,

BECAUSE the following step-by-step causal chain operates:

1. In the aged brain, elevated mitochondrial ROS drives ongoing somatic mtDNA point mutations and deletions via oxidative base damage (8-oxoguanine) and strand-break-mediated rearrangements, progressively enriching the pool of deletion-bearing mtDNA molecules and worsening electron transport chain (ETC) dysfunction. (Mitochondrial DNA replication machinery contributes to mutagenesis and age-related disease accumulation)[https://doi.org/10.1016/j.arr.2016.04.006]

2. MitoQ, accumulating ~500-fold within the mitochondrial matrix via its TPP+ cation anchor, quenches superoxide and lipid peroxyl radicals at the inner mitochondrial membrane, directly reducing the rate of new oxidative mtDNA lesion formation in remaining wild-type mitochondria. This pre-conditioning step is critical: it protects the wild-type mtDNA template pool before biogenesis is stimulated, ensuring that newly replicated mitochondria originate preferentially from undamaged templates. (ROS drives cell senescence and novel molecular mechanisms in aging)[https://doi.org/10.1155/2016/3565127]

3. Simultaneously, damaged mitochondria with high mutant heteroplasmy sustain lower membrane potential (ΔΨm) than functional organelles. MitoQ's ROS suppression paradoxically sharpens this ΔΨm differential: functional mitochondria, no longer subject to ROS-driven uncoupling, maintain robust ΔΨm, while heavily mutant mitochondria remain depolarized. This differential ΔΨm landscape primes the PINK1/Parkin mitophagy pathway to selectively eliminate the most mutation-laden organelles. [SPECULATIVE — direct evidence in aged neurons specifically is lacking, but the ΔΨm-dependent PINK1 stabilization mechanism is established in the broader literature]

4. After the two-week MitoQ pre-conditioning window has reduced the oxidative burden and initiated selective elimination of the most compromised organelles, bezafibrate is introduced. As a pan-PPAR agonist, bezafibrate activates PGC-1α, which in turn upregulates NRF1, NRF2...

SENS category: LysoSENS

Key references: • doi.org/10.1016/j.arr.2016.04.006] • doi.org/10.1155/2016/3565127] • doi.org/10.1172/jci64125] • doi.org/10.1101/gad.331272.119] • doi.org/10.1016/j.cell.2013.11.037]